Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Chugai Files NDA for a Renal Anemia Agent R744
Chugai Pharmaceutical Co., 07/23/09
Chugai Pharmaceutical Co., Ltd. announced that the company filed a new drug application for R744, a long–acting erythropoiesis–stimulating agent, for the treatment of anemia associated with chronic kidney disease with the Japanese Ministry of Health, Labour and Welfare.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor